We demonstrated that, based on plasma mNGS, additional mNGS sampling of the clinically suspected sites may improve the clinical significance of the results; on the other hand, for patients with distinct lymphopenia, especially decreased CD4+ T lymphocytes, plasma mNGS may provide a more reliable identification of pathogenic microorganisms. The gene discussed is CD4; the disease is lymphopenia.